Presentation is loading. Please wait.

Presentation is loading. Please wait.

with broad-spectrum antibiotics

Published byJames Collins Modified over 5 years ago

Similar presentations

Presentation on theme: "with broad-spectrum antibiotics"— Presentation transcript:

1 with broad-spectrum antibiotics
Figure 1 An example of phlegmonous Crohn’s disease requiring 6 weeks treatment with broad-spectrum antibiotics Figure 1 | An example of phlegmonous Crohn's disease requiring 6 weeks treatment with broad-spectrum antibiotics. a | Axial True FISP (True fast imaging with steady state precession; Siemens, Munich, Germany) T2 weighted MRI (left-hand panel) and Axial T1 fat saturated post-contrast MRI (right-hand panel) showing enhancing phlegmon of intermediate T2 signal (*), thickened terminal ileum (arrow), oedematous iliacus (Il) and psoas (Ps). b | Baseline ultrasonography of right iliac fossa (RIF) performed in longitudinal section. Long heterogeneous area (arrows) can be seen overlying the ileopsoas (left-hand panel), in keeping with phlegmon with surrounding vascularity on colour Doppler (right-hand panel). c | Follow-up ultrasonography of right iliac fossa. No phlegmon seen after 6 weeks of treatment. Bo, bowel. Patel, K. V. et al. (2016) Patient optimization for surgery relating to Crohn’s disease Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Download ppt "with broad-spectrum antibiotics"

Similar presentations

Figure 4 PET imaging in experimental pancreatic cancer

Figure 4 PET imaging in experimental pancreatic cancer
7.3c. Post-Contrast Axial CT of the Brain

7.3c. Post-Contrast Axial CT of the Brain
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 4 Paradoxical immune reconstitution inflammatory syndrome

Figure 4 Paradoxical immune reconstitution inflammatory syndrome
Figure 1 Imaging of a depressed intramucosal carcinoma

Figure 1 Imaging of a depressed intramucosal carcinoma
Figure 4 Activation of clopidogrel via cytochrome P450

Figure 4 Activation of clopidogrel via cytochrome P450
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 7 Treatment algorithm for perianal fistulizing disease

Figure 7 Treatment algorithm for perianal fistulizing disease
Figure 2 A stage-based approach to the treatment of NAFLD

Figure 2 A stage-based approach to the treatment of NAFLD
Figure 4 Simple perianal fistula

Figure 4 Simple perianal fistula
Figure 5 Identification of mucinous carcinoma

Figure 5 Identification of mucinous carcinoma
Figure 1 Worldwide incidence of CCA

Figure 1 Worldwide incidence of CCA
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
7.1b. Contrast coronal T1 Wtd MRI 7.1c. Contrast sagittal T1 Wtd MRI

7.1b. Contrast coronal T1 Wtd MRI 7.1c. Contrast sagittal T1 Wtd MRI
Figure 3 The T-cell cytokine tree in IBD

Figure 3 The T-cell cytokine tree in IBD
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 2 Modelling the effect of HCV treatment on reinfection in people who inject drugs Figure 2 | Modelling the effect of HCV treatment on reinfection.

Figure 2 Modelling the effect of HCV treatment on reinfection in people who inject drugs Figure 2 | Modelling the effect of HCV treatment on reinfection.
Figure 4 Proinflammatory immune cells and their crosstalk in patients with IBD Figure 4 | Proinflammatory immune cells and their crosstalk in patients.

Figure 4 Proinflammatory immune cells and their crosstalk in patients with IBD Figure 4 | Proinflammatory immune cells and their crosstalk in patients.

Similar presentations

Ads by Google